AEGiS-BBC: Merck abandons HIV vaccine trials BBC News OnlineImportant note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Click here to return to BBC News Online main menu
DonateNow
Print this article

Merck abandons HIV vaccine trials

BBC News - September 21, 2007


International drug company Merck has halted trials on an HIV vaccine that was regarded as one of the most promising in the fight against Aids.

Merck stopped testing the vaccine after it was judged to be ineffective.

In trials, the vaccine failed to prevent HIV infections among volunteers who were at risk of catching the virus, including gay men and sex workers.

Merck had previously expressed high hopes for the drug, which it spent 10 years developing.

'Headed for failure'

Merck's international trial, called Step, began in 2004 and involved 3,000 HIV-negative volunteers from diverse backgrounds, between the ages of 18 and 45.

Merck said that 24 of 741 volunteers who got the vaccine became infected with HIV, the virus that causes Aids.

Out of a group of 762 volunteers who were given a dummy version of the jab, 21 became infected with HIV.

An independent monitoring panel recommended discontinuing the vaccination of volunteers, saying the trial was headed for failure.

Most of the volunteers were at high risk of HIV infection.

They were repeatedly given advice about how to practise safe sex, according to Merck.

The vaccine contained a common cold virus loaded with copies of three HIV genes.

The hope was that exposure to the genes would prompt an immune response in the body so that cells containing HIV virus would be recognised and destroyed.

"Today is a very sad day for the industry because Merck's vaccine had shown an ability to turn on the immune system, which gave many people optimism it would work," said Sarah Alexander, from the HIV Vaccine Trials Network.

Doctors have said a preventative vaccine would be the best way to control the spread of HIV.


070921
BB070912


Copyright © 2007 - BBC. Reproduction of this article (other than one copy for personal reference) must be cleared through the BBC.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.